Low muscle mass at initiation of anti-TNF therapy for inflammatory bowel disease is associated with early treatment failure: a retrospective analysis

Quantitative Analysis of Human Neonatal Fc Receptor (FcRn) Tissue Expression in Transgenic Mice by Online Peptide Immuno-Affinity LC-HRMS

(2016) Yao-Yun Fan et al.   ANALYTICAL CHEMISTRY

Body composition analysis using abdominal scans from routine clinical care in patients with Crohn’s Disease

(2016) Darcy Quinn Holt et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Predicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel disease

(2016) Uri Kopylov et al.   Therapeutic Advances in Gastroenterology

Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn's disease

(2015) K. Subramaniam et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Letter: body surface area and body muscle parameters may influence adalimumab trough levels

(2015) Á. A. Csontos et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease

(2015) R. V. Bryant et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management

(2015) N. S. Ding et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

What is the best reference site for a single MRI slice to assess whole-body skeletal muscle and adipose tissue volumes in healthy adults?1

(2015) Lisa Schweitzer et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

The Pharmacokinetics of Biologics: A Primer

(2015) Diane R. Mould   DIGESTIVE DISEASES

Visceral Adipose Tissue in Patients with Crohnʼs Disease Correlates with Disease Activity, Inflammatory Markers, and Outcome

(2015) Carsten Büning et al.   INFLAMMATORY BOWEL DISEASES

Segmentation and quantification of adipose tissue by magnetic resonance imaging

(2015) Houchun Harry Hu et al.   MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE

Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease

(2014) Iris Dotan et al.   INFLAMMATORY BOWEL DISEASES

P415 MRI assessment of body composition in paediatric Crohn's disease; intra-abdominal adipose tissue association with disease severity

(2014) D. Thangarajah et al.   Journal of Crohns & Colitis

Systematic review: body composition in adults with inflammatory bowel disease

(2013) R. V. Bryant et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn’s disease?

(2013) Mahesh Bhalme et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

American Gastroenterological Association Institute Technical Review on the Use of Thiopurines, Methotrexate, and Anti–TNF-α Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease

(2013) Themistocles Dassopoulos et al.   GASTROENTEROLOGY

Increased Body Mass Index Is Associated with Earlier Time to Loss of Response to Infliximab in Patients with Inflammatory Bowel Disease

(2013) Jason W. Harper et al.   INFLAMMATORY BOWEL DISEASES

Relationship Between Dual-Energy X-Ray Absorptiometry Volumetric Assessment and X-ray Computed Tomography–Derived Single-Slice Measurement of Visceral Fat

(2013) Yi Xia et al.   JOURNAL OF CLINICAL DENSITOMETRY

Estimating dual-energy X-ray absorptiometry-derived total body skeletal muscle mass using single-slice abdominal magnetic resonance imaging in obese subjects with and without diabetes: a pilot study

(2012) S T Baker et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Single Slice vs. Volumetric MR Assessment of Visceral Adipose Tissue: Reliability and Validity Among the Overweight and Obese

(2012) Greg Maislin et al.   Obesity

Predictors of dose escalation of adalimumab in a prospective cohort of Crohn’s disease patients

(2011) E. Bultman et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Review article: loss of response to anti-TNF treatments in Crohn’s disease

(2011) S. Ben-Horin et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Ratio of Visceral to Subcutaneous Fat Area Is a Biomarker of Complicated Crohn's Disease

(2011) Bara Erhayiem et al.   Clinical Gastroenterology and Hepatology

Pharmacokinetic Properties of Infliximab in Children and Adults with Crohn's Disease: A Retrospective Analysis of Data from 2 Phase III Clinical Trials

(2011) Adedigbo A. Fasanmade et al.   CLINICAL THERAPEUTICS

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose and How to Predict Response?

(2010) Geert R D'Haens et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Neonatal Fc Receptor: From Immunity to Therapeutics

(2010) Timothy T. Kuo et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease

(2009) Konstantinos Karmiris et al.   GASTROENTEROLOGY

A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care

(2008) Marina Mourtzakis et al.   Applied Physiology Nutrition and Metabolism